MSToronto2026 Day Three: What Will We Take Away from Toronto?
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
MSToronto2026 Day Three: What Will We Take Away from Toronto?
-
Letto da:
-
Di:
Three days of science, debate and discovery.
For the final episode in our special MSToronto2026 podcast series, ECTRIMS Executive Committee member Jaume Sastre-Garriga joins host Brett Drummond direct from Toronto.
Together, they unpack the key insights from Day Three, including the Late Breaking Abstract session, before stepping back to reflect on the Joint Meeting as a whole.
What stood out across the week? Which developments and conversations could have lasting significance? And as thousands of researchers and clinicians prepare to leave Toronto, what comes next for the MS field?
Recorded at the 10th Joint ACTRIMS-ECTRIMS Meeting, this is our final dispatch from Toronto – bringing together the science, conversations and ideas that shaped an extraordinary week.
This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.